Literature DB >> 19959874

Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys.

Steven E Bosinger1, Qingsheng Li, Shari N Gordon, Nichole R Klatt, Lijie Duan, Luoling Xu, Nicholas Francella, Abubaker Sidahmed, Anthony J Smith, Elizabeth M Cramer, Ming Zeng, David Masopust, John V Carlis, Longsi Ran, Thomas H Vanderford, Mirko Paiardini, R Benjamin Isett, Don A Baldwin, James G Else, Silvija I Staprans, Guido Silvestri, Ashley T Haase, David J Kelvin.   

Abstract

Natural SIV infection of sooty mangabeys (SMs) is nonprogressive despite chronic virus replication. Strikingly, it is characterized by low levels of immune activation, while pathogenic SIV infection of rhesus macaques (RMs) is associated with chronic immune activation. To elucidate the mechanisms underlying this intriguing phenotype, we used high-density oligonucleotide microarrays to longitudinally assess host gene expression in SIV-infected SMs and RMs. We found that acute SIV infection of SMs was consistently associated with a robust innate immune response, including widespread upregulation of IFN-stimulated genes (ISGs) in blood and lymph nodes. While SMs exhibited a rapid resolution of ISG expression and immune activation, both responses were observed chronically in RMs. Systems biology analysis indicated that expression of the lymphocyte inhibitory receptor LAG3, a marker of T cell exhaustion, correlated with immune activation in SIV-infected RMs but not SMs. Our findings suggest that active immune regulatory mechanisms, rather than intrinsically attenuated innate immune responses, underlie the low levels of immune activation characteristic of SMs chronically infected with SIV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19959874      PMCID: PMC2786806          DOI: 10.1172/JCI40115

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  77 in total

1.  Immunology. Versatile defensins.

Authors:  Tomas Ganz
Journal:  Science       Date:  2002-11-01       Impact factor: 47.728

2.  DAVID: Database for Annotation, Visualization, and Integrated Discovery.

Authors:  Glynn Dennis; Brad T Sherman; Douglas A Hosack; Jun Yang; Wei Gao; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-04-03       Impact factor: 13.583

3.  The theta-defensin, retrocyclin, inhibits HIV-1 entry.

Authors:  Carsten Münk; Ge Wei; Otto O Yang; Alan J Waring; Wei Wang; Teresa Hong; Robert I Lehrer; Nathaniel R Landau; Alexander M Cole
Journal:  AIDS Res Hum Retroviruses       Date:  2003-10       Impact factor: 2.205

4.  Turnover rates of B cells, T cells, and NK cells in simian immunodeficiency virus-infected and uninfected rhesus macaques.

Authors:  Rob J De Boer; Hiroshi Mohri; David D Ho; Alan S Perelson
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

5.  Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

Authors:  Guido Silvestri; Donald L Sodora; Richard A Koup; Mirko Paiardini; Shawn P O'Neil; Harold M McClure; Silvija I Staprans; Mark B Feinberg
Journal:  Immunity       Date:  2003-03       Impact factor: 31.745

Review 6.  Disrupting T-cell homeostasis: how HIV-1 infection causes disease.

Authors:  Daniel C Douek
Journal:  AIDS Rev       Date:  2003 Jul-Sep       Impact factor: 2.500

7.  Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

Authors:  Mette D Hazenberg; Sigrid A Otto; Birgit H B van Benthem; Marijke Th L Roos; Roel A Coutinho; Joep M A Lange; Dörte Hamann; Maria Prins; Frank Miedema
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

8.  Functional genomic analysis of the response of HIV-1-infected lymphatic tissue to antiretroviral therapy.

Authors:  Qingsheng Li; Timothy Schacker; John Carlis; Gregory Beilman; Phuong Nguyen; Ashley T Haase
Journal:  J Infect Dis       Date:  2004-02-05       Impact factor: 5.226

Review 9.  Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis.

Authors:  M Chawla-Sarkar; D J Lindner; Y-F Liu; B R Williams; G C Sen; R H Silverman; E C Borden
Journal:  Apoptosis       Date:  2003-06       Impact factor: 4.677

10.  Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor.

Authors:  Linqi Zhang; Wenjie Yu; Tian He; Jian Yu; Rebecca E Caffrey; Enrique A Dalmasso; Siyu Fu; Thang Pham; Jianfeng Mei; Jaclyn J Ho; Wenyong Zhang; Peter Lopez; David D Ho
Journal:  Science       Date:  2002-09-26       Impact factor: 47.728

View more
  231 in total

1.  CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques.

Authors:  Jessica E Taaffe; Steven E Bosinger; Gregory Q Del Prete; James G Else; Sarah Ratcliffe; Christopher D Ward; Thi Migone; Mirko Paiardini; Guido Silvestri
Journal:  J Med Primatol       Date:  2011-11-14       Impact factor: 0.667

2.  Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis.

Authors:  Adriano Boasso; Caroline M Royle; Spyridon Doumazos; Veronica N Aquino; Mara Biasin; Luca Piacentini; Barbara Tavano; Dietmar Fuchs; Francesco Mazzotta; Sergio Lo Caputo; Gene M Shearer; Mario Clerici; David R Graham
Journal:  Blood       Date:  2011-09-19       Impact factor: 22.113

Review 3.  Natural SIV hosts: showing AIDS the door.

Authors:  Ann Chahroudi; Steven E Bosinger; Thomas H Vanderford; Mirko Paiardini; Guido Silvestri
Journal:  Science       Date:  2012-03-09       Impact factor: 47.728

Review 4.  HIV and inflammation: mechanisms and consequences.

Authors:  Peter W Hunt
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

5.  Therapeutic depletion of natural killer cells controls persistent infection.

Authors:  Stephen N Waggoner; Keith A Daniels; Raymond M Welsh
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

Review 6.  Pathogenic Role of Type I Interferons in HIV-Induced Immune Impairments in Humanized Mice.

Authors:  Lishan Su
Journal:  Curr HIV/AIDS Rep       Date:  2019-06       Impact factor: 5.071

7.  Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.

Authors:  David Palesch; Steven E Bosinger; Maud Mavigner; James M Billingsley; Cameron Mattingly; Diane G Carnathan; Mirko Paiardini; Ann Chahroudi; Thomas H Vanderford; Guido Silvestri
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

8.  Transcriptional profiling of experimental CD8(+) lymphocyte depletion in rhesus macaques infected with simian immunodeficiency virus SIVmac239.

Authors:  Steven E Bosinger; Simon P Jochems; Kathryn A Folkner; Timothy L Hayes; Nichole R Klatt; Guido Silvestri
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

Review 9.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

Review 10.  Decoding the complexity of type I interferon to treat persistent viral infections.

Authors:  Elizabeth B Wilson; David G Brooks
Journal:  Trends Microbiol       Date:  2013-11-08       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.